<DOC>
	<DOCNO>NCT00373347</DOCNO>
	<brief_summary>The aim study see change quality life patient undergoing radical prostatectomy .</brief_summary>
	<brief_title>Identification New Serum Diagnostic Markers Hepatocellular Carcinoma</brief_title>
	<detailed_description>Liver cancer deadly cancer typically hard diagnose treat . The currently use blood marker clinical diagnosis liver cancer alpha-feto protein ( AFP ) , miss 40-60 % patient liver cancer lack sufficient specificity sensitivity . The purpose study identify blood marker ability diagnose liver cancer improve accuracy , use alone conjunction AFP . The aim study identify new blood marker liver cancer use increase rate accurate diagnosis malignancy .</detailed_description>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<criteria>Patients diagnose liver cancer base biopsy serum AFP level , associate characteristic hypervascular liver tumor triphasic spiral CT scan MRI . Patients noncancer liver condition cirrhosis , adenoma , cholangioma , nodular hyperplasia . Patients hepatitis B hepatitis C viral infection associate liver cancer . Patients exclude , upon look medical record , information require data analysis missing .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>